Content area
Vivo Bio Tech Ltd (511509) - Financial Analysis Review
Vivo Bio Tech Ltd (Vivo Bio Tech) is a contract research organization that provides drug development and discovery services. The organization offers SPF mice and rats, SPF guinea pigs, lab animal diets, lab animal serum and plasma models. It offers services in the areas of in vitro, in vivo, toxicity studies, pharmacological investigations, analytical services, pharmacokinetics and toxicokinetic studies and among others.
GlobalData's Vivo Bio Tech Ltd (511509) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.
Vivo Bio Tech Ltd Key Recent Developments:
Aug 20,2025: Vivo Bio Tech Secures Pre-Clinical Testing Contract Valued at ?10.75 Crores
Jun 30,2025: Vivo Bio Tech : Intimation Regarding Completion of Term of Mrs. Kunda Kalpana, Independent Director
Jun 11,2025: Vivo Bio Tech Appoints Priya Rajender Goda as Additional Independent Director
May 06,2025: Vivo Bio Tech : Resignation of Non-Executive Non-Independent Director
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.